Jacobs Levy Equity Management
INSM icon

Jacobs Levy Equity Management’s Insmed INSM Stock Holding History

Jacobs Levy Equity Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-93,158
Closed -$2.91M – 1024
2017
Q3 		$2.91M Buy
93,158
+75,008
+413% +$1.43M 0.06% 352
2017
Q2 		$311K Buy
+18,150
New +$310K 0.01% 766

Other funds holding INSM

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Jacobs Levy Equity Management's INSM Position: Q4 2017 in Review

Jacobs Levy Equity Management sold out of Insmed (INSM) in Q4 2017, closing a stake of 93,158 shares — an estimated $2.91M sold.

Jacobs Levy Equity Management first reported a position in INSM in Q2 2017 and held it in 2 quarters. The position peaked at $2.91M in Q3 2017. 129 funds tracked by Wall St. Rank hold INSM as of Q4 2017.

  • Jacobs Levy Equity Management reported no remaining Insmed position as of Q4 2017 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 93,158 Insmed shares in Q4 2017, an estimated $2.91M.
  • Jacobs Levy Equity Management first reported a position in Insmed in Q2 2017 and held it in 2 quarters.
  • Jacobs Levy Equity Management's Insmed position peaked at $2.91M in Q3 2017.
  • 129 funds tracked by Wall St. Rank held Insmed as of Q4 2017.

Based on Jacobs Levy Equity Management's 13F filing for Q4 2017, filed 13 Feb 2018.